[
  {
    "ts": "2026-01-06T10:30:00+00:00",
    "headline": "Big Pharma Has More Going for It Than Obesity Drugs",
    "summary": "Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.",
    "url": "https://www.wsj.com/health/pharma/big-pharma-has-more-going-for-it-than-obesity-drugs-35ffd102?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "718b31ea-161c-37e0-b9a9-30d517b0adda",
      "content": {
        "id": "718b31ea-161c-37e0-b9a9-30d517b0adda",
        "contentType": "STORY",
        "title": "Big Pharma Has More Going for It Than Obesity Drugs",
        "description": "",
        "summary": "Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.",
        "pubDate": "2026-01-06T10:30:00Z",
        "displayTime": "2026-01-06T10:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/718b31ea-161c-37e0-b9a9-30d517b0adda/big-pharma-has-more-going-for.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/e4b5dcc738daaf9952e09fd2749449f5",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7RMo0RAoQIXBecVowGWgxA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/e4b5dcc738daaf9952e09fd2749449f5.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0b65xm2vuQmoOxj8Df4WNw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/e4b5dcc738daaf9952e09fd2749449f5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/big-pharma-has-more-going-for-it-than-obesity-drugs-35ffd102?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-06T12:00:00+00:00",
    "headline": "OncoNano Medicine Announces Research Collaboration with Gilead to Apply ON-BOARD™ Delivery Technology to Gilead’s Drug Candidate",
    "summary": "DALLAS, January 06, 2026--OncoNano Medicine, Inc. (\"OncoNano\") today announced a research collaboration with Gilead Sciences, Inc. (Nasdaq: GILD) (\"Gilead\") to evaluate OncoNano’s ON-BOARD™ encapsulation technology with Gilead’s drug candidate.",
    "url": "https://finance.yahoo.com/news/onconano-medicine-announces-research-collaboration-120000537.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "8cfc070a-90a2-3130-b31a-feb0dc6e3a56",
      "content": {
        "id": "8cfc070a-90a2-3130-b31a-feb0dc6e3a56",
        "contentType": "STORY",
        "title": "OncoNano Medicine Announces Research Collaboration with Gilead to Apply ON-BOARD™ Delivery Technology to Gilead’s Drug Candidate",
        "description": "",
        "summary": "DALLAS, January 06, 2026--OncoNano Medicine, Inc. (\"OncoNano\") today announced a research collaboration with Gilead Sciences, Inc. (Nasdaq: GILD) (\"Gilead\") to evaluate OncoNano’s ON-BOARD™ encapsulation technology with Gilead’s drug candidate.",
        "pubDate": "2026-01-06T12:00:00Z",
        "displayTime": "2026-01-06T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/3d7fc4ee21e751d17ba2dfe893868e41",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wCXwFoAoFWQzFyyJRxNX5A--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/3d7fc4ee21e751d17ba2dfe893868e41.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aiPL4XqkA6gouDWujfbvxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/3d7fc4ee21e751d17ba2dfe893868e41.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/onconano-medicine-announces-research-collaboration-120000537.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/onconano-medicine-announces-research-collaboration-120000537.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-06T14:13:00+00:00",
    "headline": "TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Report 2026-2030: Roche, Gilead Sciences, Merck, Arcus Biosciences, Compugen, and Vir Biotechnology Advance Deep Oncology Pipelines",
    "summary": "The TIGIT inhibitors market is poised for growth with the anticipated drug approval by 2030, over 40 drugs in clinical trials, and a dynamic landscape involving major pharmaceutical and biotech firms. Opportunities exist in enhancing cancer immunotherapy, particularly for tumor types resistant to current treatments, through combination regimens and biomarker-driven strategies.Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The \"TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook",
    "url": "https://finance.yahoo.com/news/tigit-inhibitors-drugs-clinical-trials-141300202.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "c06f4821-64a0-353e-9af8-ddceff8c3bc5",
      "content": {
        "id": "c06f4821-64a0-353e-9af8-ddceff8c3bc5",
        "contentType": "STORY",
        "title": "TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Report 2026-2030: Roche, Gilead Sciences, Merck, Arcus Biosciences, Compugen, and Vir Biotechnology Advance Deep Oncology Pipelines",
        "description": "",
        "summary": "The TIGIT inhibitors market is poised for growth with the anticipated drug approval by 2030, over 40 drugs in clinical trials, and a dynamic landscape involving major pharmaceutical and biotech firms. Opportunities exist in enhancing cancer immunotherapy, particularly for tumor types resistant to current treatments, through combination regimens and biomarker-driven strategies.Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The \"TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Outlook",
        "pubDate": "2026-01-06T14:13:00Z",
        "displayTime": "2026-01-06T14:13:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc",
          "originalWidth": 480,
          "originalHeight": 58,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_MlAqEncKPaKK77zrkRGmQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 480,
              "height": 58,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/caWFqk489OEmv3xI33JamQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tigit-inhibitors-drugs-clinical-trials-141300202.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tigit-inhibitors-drugs-clinical-trials-141300202.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "RCUS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]